HITGEN INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.52 CNY | +1.27% |
|
+16.45% | -9.81% |
| 04-24 | HitGen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-23 | HitGen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 508
Sales per Business
| CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Deoxyribonucleic Acid Encoded Compound Library Screening Service
26.3
%
| - | - | 98 | 26.3 % | - |
Fragment-based Drug Design/Structure-based Drug Design Research & Development Services
24.5
%
| - | - | 91 | 24.5 % | - |
Deoxyribonucleic Acid Encoded Compound Library Customization Service
22.8
%
| - | - | 85 | 22.8 % | - |
Chemical Synthesis Services
14.0
%
| - | - | 52 | 14.0 % | - |
New Drug Custom Development
5.2
%
| - | - | 19 | 5.2 % | - |
Others
3.8
%
| - | - | 14 | 3.8 % | - |
Compound Structure Intellectual Property Transfer Fee
2.8
%
| - | - | 10 | 2.8 % | - |
New Drug Research Equity Transfer
0.5
%
| 17 | 5.2 % | 2 | 0.5 % | -88.90% |
Sales per region
| CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
67.3
%
| 164 | 49.8 % | 250 | 67.3 % | +52.21% |
China
16.9
%
| 69 | 20.8 % | 63 | 16.9 % | -8.40% |
Denmark
5.1
%
| 20 | 6.2 % | 19 | 5.1 % | -8.13% |
United Kingdom
3.9
%
| 11 | 3.3 % | 15 | 3.9 % | +33.50% |
Japan
2.6
%
| 5 | 1.4 % | 10 | 2.6 % | +103.57% |
South Korea
1.4
%
| 7 | 2.2 % | 5 | 1.4 % | -31.03% |
France
1.2
%
| 41 | 12.4 % | 5 | 1.2 % | -88.72% |
Other Countries
1.0
%
| 4 | 1.1 % | 4 | 1.0 % | +1.29% |
Germany
0.4
%
| 6 | 1.9 % | 1 | 0.4 % | -76.03% |
Ireland
0.2
%
| 3 | 0.8 % | 1 | 0.2 % | -70.11% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Jin Li
CEO | Chief Executive Officer | 61 | 12-02-21 |
Eliza Liu
DFI | Director of Finance/CFO | 54 | 23-04-26 |
Barry A Morgan
CTO | Chief Tech/Sci/R&D Officer | 77 | 16-05-31 |
Sui Bo Li
BRD | Director/Board Member | 63 | 18-09-30 |
Lei Zhu
IRC | Investor Relations Contact | 36 | 19-06-30 |
Shi Wei Geng
SEC | Corporate Secretary | 37 | 15-09-30 |
Guan Sai Liu
PRN | Corporate Officer/Principal | 42 | 13-08-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jin Li
CEO | Chief Executive Officer | 61 | 12-02-21 |
Hai Zong Yu
BRD | Director/Board Member | 60 | 19-03-23 |
Jian Guo Li
BRD | Director/Board Member | 63 | 19-03-23 |
Yong Cun Chen
BRD | Director/Board Member | 59 | 19-03-23 |
Kai Lu
BRD | Director/Board Member | 71 | 12-01-31 |
Ze Wu Liu
BRD | Director/Board Member | 71 | 19-03-23 |
Chen Hui Xu
CHM | Chairman | 58 | 12-01-31 |
Dan Liu
BRD | Director/Board Member | 41 | 22-05-26 |
Sui Bo Li
BRD | Director/Board Member | 63 | 18-09-30 |
Shao Lin Hu
BRD | Director/Board Member | 38 | 22-05-26 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 400,680,000 | 135,670,177 ( 33.86 %) | 1,238,700 ( 0.3091 %) | 33.86 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
HITGEN INC. 0.31% | 1,238,700 | 0.31% | 2,276,037 $ |
Company contact information
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.52
CNY
Average target price
16
CNY
Spread / Average Target
+18.34%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.81% | 746M | |
| -1.65% | 104B | |
| +6.75% | 97.47B | |
| +5.71% | 22.25B | |
| -12.60% | 21.68B | |
| -9.70% | 18.2B | |
| -39.98% | 17.02B | |
| -10.17% | 16.36B | |
| +6.12% | 14.39B | |
| +35.47% | 12.37B |
- Stock Market
- Equities
- 688222 Stock
- Company HitGen Inc.
